Publicaciones en las que colabora con Juan Antonio Berto Botella (14)

2024

  1. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

2021

  1. Bronchial Artery Pseudoaneurysm and Mediastinal Hematoma after EBUS-TBNA

    Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 142-143

  2. Chronic rhinosinusitis is associated with prolonged SARS-CoV-2 RNA shedding in upper respiratory tract samples: A case-control study

    Journal of Internal Medicine, Vol. 289, Núm. 6, pp. 921-925

  3. Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography

    Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 101-106

2020

  1. Exploring the association between emphysema phenotypes and low bone mineral density in smokers with and without copd

    International Journal of COPD, Vol. 15, pp. 1823-1829

2019

  1. Emphysema phenotypes and lung cancer risk

    PLoS ONE, Vol. 14, Núm. 7

  2. Trabecular bone score in active or former smokers with and without COPD

    PLoS ONE, Vol. 14, Núm. 2

2018

  1. Pulmonary arterial enlargement predicts long-term survival in COPD patients

    PLoS ONE, Vol. 13, Núm. 4

2017

  1. Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation

    Chest, Vol. 151, Núm. 2, pp. 358-365

  2. Telomere length, COPD and emphysema as risk factors for lung cancer

    European Respiratory Journal

2016

  1. The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development

    Lung Cancer, Vol. 97, pp. 28-34

2015

  1. Improving selection criteria for lung cancer screening: The potential role of emphysema

    American Journal of Respiratory and Critical Care Medicine, Vol. 191, Núm. 8, pp. 924-931

  2. Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)

    Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 169-176

  3. Lung cancer in patients with chronic obstructive pulmonary disease: Development and validation of the COPD lung cancer screening score

    American Journal of Respiratory and Critical Care Medicine, Vol. 191, Núm. 3, pp. 285-291